LncRNA NameLINC00673
Variant TypeSNP
Variant IDrs11655237
Specieshuman
Circulating
Survival
CeRNA
Methylation
Enhancer
Drug
Disease/Traitpancreatic cancer
LncRNA Target GenemiR-1231
Tissuepancreatic cancer tissues, cell lines (BXPC-3 and CFPAC-1)
ExperimentqPCR, Flow cytometry assay etc.
Function DescriptionFlow cytometry analysis indicated that LINC00673 overexpression resulted in a substantial accumulation of PDAC cells in G0/G1 phase, accompanied by a substantial decrease in the number of cells in S phase. LINC00673 is able to reinforce the interaction of PTPN11 with PRPF19, an E3 ubiquitin ligase, and promote PTPN11 degradation through ubiquitination, which causes diminished SRC-ERK oncogenic signaling and enhanced activation of the STAT1-dependent antitumor response. A G>A change at rs11655237 in exon 4 of LINC00673 creates a target site for miR-1231 binding, which diminishes the effect of LINC00673 in an allele-specific manner and thus confers susceptibility to tumorigenesis.
Pubmed ID27213290
Year2016
TitlePancreatic cancer risk variant in LINC00673 creates a miR-1231 binding site and interferes with PTPN11 degradation.
External Links
Links For LINC00673GeneCards HGNC NONCODE LncRNAWiki lncrnadb
Links For pancreatic cancerOMIM Cosmic
Links For rs11655237 dbSNP ClinVar OMIM